Although the results were obtained on the limited number of cases and marker genes, the identified Group 3 showed all features of poor prognosis, including frequent metastases, LCA pathology and presence of tumors with MYCC amplification. The gene discussed is MYC; the disease is Leber congenital amaurosis.